Entities / Company
Zai Lab Limited.
Zai Lab is an innovative, research-based, commercial stage biopharmaceutical company based in China and the U.S. focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world.
- Reports this week
- 0
- Active events
- 0
- Connections
- 19
What's happening
One to three months ago
Gone quiet
No new reports in 90+ days-
NMPA granted designation for TTFields targeting pancreatic cancer, with Zai Lab participating in a study in Greater China.Some support2 reports
-
Both Zai Lab Limited and Apellis Pharmaceuticals are identified as high-growth biopharmaceutical companies.Speculative1 report
-
Zai Lab Limited is based in the United States.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Zai Lab Limited this week
News at the entities that move Zai Lab Limited most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Zai Lab Limited
Connections
The 2 strongest of 19, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
Zai Lab sought and received Fast Track designation from the FDA for its drug ZL-1310.
-
Samantha Du Structural
Samantha Du serves as the Founder, Chairperson, and CEO of Zai Lab Limited.
History
Events by the month they beganJune 2026
4 events- Samantha Du was appointed Founder, Chairperson, and CEO of Zai Lab Limited, as reported by HKT.
- NMPA granted designation for TTFields targeting pancreatic cancer, with Zai Lab participating in a study in Greater China.
- Both Zai Lab Limited and Apellis Pharmaceuticals are identified as high-growth biopharmaceutical companies.
- Zai Lab Limited is based in the United States.